论文信息 - Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis. - 字舞流文

Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.

S. Jolles | M. Rustin | J. Hughes

[1] S. Whittaker,et al. Dermatological uses of high-dose intravenous immunoglobulin. , 1998, Archives of dermatology.

[2] S. Kaveri,et al. Mechanisms of action of intravenous immune globulin in immune‐mediated diseases , 1996, Clinical and experimental immunology.

[3] E. Gelfand,et al. Intravenous immune globulin: an alternative therapy in steroid‐dependent allergic diseases , 1996, Clinical and experimental immunology.

[4] H. Kimata. High dose gammaglobulin treatment for atopic dermatitis. , 1994, Archives of disease in childhood.

[5] K. Cooper,et al. Atopic dermatitis: recent trends in pathogenesis and therapy. , 1994, The Journal of investigative dermatology.

[6] S. Romagnani. Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[7] C. Heusser,et al. Detection of intracellular cytokines by flow cytometry. , 1993, Journal of immunological methods.

[8] S. Romagnani. Regulation and deregulation of human IgE synthesis. , 1990, Immunology today.

[9] C. Bulpitt,et al. Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomised controlled trial. , 1984, British medical journal.